Attenuation of cisplatin ototoxicity by otoprotective effects of nanoencapsulated curcumin and dexamethasone in a Guinea pig model

Otology and Neurotology

Volumn 35, Issue 7, 2014, Pages 1131-1139

  Salehi, Pezhman ^a   Akinpelu, Olubunmi Victoria ^a   Waissbluth, Sofia ^a   Peleva, Emilia ^a   Meehan, Brian ^b   Rak, Janusz ^b   Daniel, Sam J ^a,c  

^a MCGILL UNIVERSITY   (Canada)

^b RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

Cisplatin; Curcumin; Dexamethasone; Nanoencapsulated Ototoxicity

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CURCUMIN; DEXAMETHASONE;

ANIMAL; CELL LINE; COCHLEA; CORTI ORGAN; DRUG EFFECTS; EVOKED BRAIN STEM AUDITORY RESPONSE; FEMALE; GUINEA PIG; HEARING; HEARING LOSS; PATHOLOGY; TREATMENT OUTCOME;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE; CISPLATIN; COCHLEA; CURCUMIN; DEXAMETHASONE; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; GUINEA PIGS; HEARING; HEARING LOSS; ORGAN OF CORTI; TREATMENT OUTCOME;

EID: 85027919235     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0000000000000403     Document Type: Article

References (29)

1. Kelland LR, Farrell NP. Platinum-Based Drugs in Cancer Therapy. Totowa, NJ: Humana Press, 2000.
2. Rybak LP. Mechanisms of cisplatin ototoxicity and progress in otoprotection. Curr Opin Otolaryngol Head Neck Surg 2007;15: 364-9.
3. Al-Khatib T, Cohen N, Carret AS, et al. Cisplatinum ototoxicity in children, long-term follow up. Int J Pediatr Otorhinolaryngol 2010;74:913-9.
4. Kolinsky DC, Hayashi SS, Karzon R, et al. Late onset hearing loss: a significant complication of cancer survivors treated with Cisplatin containing chemotherapy regimens. J Pediatr Hematol Oncol 2010;32: 119-23.
5. Aggarwal BB, Sung B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci 2009;30:85-94.
6. Mohanty C, Sahoo SK. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. Biomaterials 2010;31:6597-611.
7. Asai A, Miyazawa T. Occurrence of orally administered curcuminoid as glucuronide and glucuronide/sulfate conjugates in rat plasma. Life Sci 2000;67:2785-93.
8. Waissbluth S, Salehi P, He X, et al. Systemic dexamethasone for the prevention of cisplatin-induced ototoxicity. Eur Arch Otorhinolaryngol 2013;270:1597-605.
9. Rinehart J, Keville L, Neidhart J, et al. Hematopoietic protection by dexamethasone or granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients treated with carboplatin and ifosfamide. Am J Clin Oncol 2003;26:448-58.
10. Salehi P, Makhoul G, Roy R, et al. Curcumin loaded NIPAAM/VP/ PEG-A nanoparticles: physicochemical and chemopreventive properties. J Biomater Sci Polym Ed 2013;24:574-88.
11. Rice SA, Fish KJ. Aesthetic toxicity. New York, NY: Raven Press, 1994.
12. Bisht S, Mizuma M, Feldmann G, et al. Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer. Mol Cancer Ther 2010;9:2255-64.
13. Waissbluth S, Dupuis I, Daniel SJ. Protective effect of erdosteine against cisplatin-induced ototoxicity in a guinea pig model. Otolaryng Head Neck 2012;146:627-32.
14. Saito T, Manabe Y, Honda N, et al. Semiquantitative analysis by scanning electron microscopy of cochlear hair cell damage by ototoxic drugs. Scanning Microsc 1995;9:271-80.
15. Smith RJH, Shearer AE, Hildebrand MS, et al. Deafness and hereditary hearing loss overview. GeneReviews. Seattle 2013;1993-2013.
16. Riga MG, Chelis L, Kakolyris S, et al. Transtympanic injections of N-acetylcysteine for the prevention of cisplatin-induced ototoxicity: a feasible method with promising efficacy. Am J Clin Oncol 2013;36:1-6.
17. Rybak LP, Mukherjea D, Jajoo S, Ramkumar V. Cisplatin ototoxicity and protection: clinical and experimental studies. Tohoku J Exp Med 2009;219:177-86.
18. Ekborn A, Hansson J, Ehrsson H, et al. High-dose Cisplatin with amifostine: ototoxicity and pharmacokinetics. Laryngoscope 2004;114:1660-7.
19. Thomas Dickey D, Muldoon LL, Kraemer DF, Neuwelt EA. Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model. Hear Res 2004;193:25-30.
20. Shin YS, Song SJ, Kang S, Hwang HS, Jung YS, Kim CH. Novel synthetic protective compound, KR-22335, against cisplatin-induced auditory cell death. J Appl Toxicol 2014;34:191-204.
21. Bazolu MS, Eren E, Aslan H, Bingölballi AG, Oztürkcan S, Katilmiz H. Prevention of cisplatin ototoxicity: efficacy of mi-cronized flavonoid fraction in a guinea pig model. Int J Pediatr Otorhinolaryngol 2012;76:1343-6.
22. Cakil B, Basar FS, Atmaca S, Cengel SK, Tekat A, Tanyeri Y. The protective effect of Ginkgo biloba extract against experimental cisplatin ototoxicity: animal research using distortion product otoacoustic emissions. J Laryngol Otol 2012;126:1097-101.
23. Erdem T, Bayindir T, Filiz A, Iraz M, Selimoglu E. The effect of resveratrol on the prevention of cisplatin ototoxicity. Eur Arch Otorhinolaryngol 2012;269:2185-8.
24. Fausti SA, Henry JA, Schaffer HI, et al. High-frequency monitoring for early detection of cisplatin ototoxicity. Arch Otolaryngol Head Neck Surg 1993;119:661-6.
25. Rybak LP, Husain K, Evenson L, et al. Protection by 4-methylthiobenzoic acid against cisplatin-induced ototoxicity: antioxidant system. Pharmacol Toxicol 1997;81:173-9.
26. Noori S, Mahboob T. Antioxidant effect of carnosine pretreatment on cisplatin-induced renal oxidative stress in rats. Ind. Clin Biochem 2010;25:86-91.
27. Omar HM, Ahmed EA, Abdel-Ghafar S, et al. Hepatoprotective effects of vitamin C, DPPD, and L-cysteine against cisplatin-induced oxidative stress in male rats. J Biol Earth Sci 2012;2: B28-36.
28. Ravi R, Somani SM, Rybak LP. Mechanism of cisplatin ototoxicity: antioxidant system. Pharmacol Toxicol 1995;76:386-94.
29. Zhang J G, Lindup WE. Differential effects of cisplatin on the production of NADH-dependent superoxide and the activity of antioxidant enzymes in rat renal cortical slices in vitro. Pharmacol Toxicol 1996;79:191-8.